Watch the video here!
Are you interested in learning more about the clinical trials offered for the treatment of sarcoma? Join us November 29th as we discuss the “CLINICAL TRIAL BASICS” with current Leiomyosarcoma warrior Jennifer Ensey.
Jennifer has participated in two clinical trials in additional to multiple other treatment options. Her aggressive and proactive approach to her treatment process has kept her sarcoma at bay for over 7 years. LIVE on Facebook Thursday November 29th Jennifer will explain what a trial is, how to choose a trial, and her experience as a patient in sarcoma clinical trials.
Jennifer received the following treatments/medication during clinical trials:
- Tribectedin - Now FDA Approved for Sarcoma Treatment -On October 23, the Food and Drug Administration (FDA) approved trabectedin(Yondelis®) for the treatment of two subtypes of soft tissue sarcomas: liposarcoma and leiomyosarcoma. The approval is for patients whose cancers are advanced or cannot be removed by surgery and who have already been treated with anthracycline-based chemotherapy.
- Dacarbazine: Dacarbazine is used for metastatic malignant melanoma, Hodgkin's disease, soft tissue sarcomas, neuroblastoma, fibrosarcomas, rhabdomyosarcoma, islet cell carcinoma, and medullary carcinoma of the thyroid.
After the video airs on November 29th the Northwest Sarcoma Foundation invites you to continue the conversation on our online forum via SmartPatients.com. This online community provides a place for patients, and caretakers to connect with other people affected by sarcoma. Have a question, or just need someone who can relate? Connect on SmartPatients!
Not able to tune in on November 29th? No problem! The link to this and future Educational series videos can be found here!